Serum chitotriosidase and YKL-40 in acute pancreatitis: Reliability as prognostic marker for disease severity and correlation with inflammatory markers

被引:2
|
作者
Cetin, Ece Unal [1 ]
Kamis, Fatih [1 ]
Cetin, Adil Ugur [1 ]
Beyazit, Yavuz [2 ]
Kekilli, Murat [3 ]
机构
[1] Canakkale Onsekiz Mart Univ, Fac Med, Dept Internal Med, Canakkale, Turkey
[2] Canakkale Onsekiz Mart Univ, Fac Med, Dept Internal Med, Div Gastroenterol, Canakkale, Turkey
[3] Gazi Univ, Fac Med, Dept Internal Med, Div Gastroenterol, Ankara, Turkey
关键词
  Acute pancreatitis; YKL-40; chitotriosidase; inflammation; C-REACTIVE PROTEIN; TRYPSINOGEN ACTIVATION PEPTIDE; MEAN PLATELET VOLUME; INDICATOR; SPUTUM;
D O I
10.3906/sag-2106-59
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/aim: Chitotriosidase and YKL-40, also called chitinase 3-like protein 1, are homologs of family 18 glycosyl hydrolases, secreted by human macrophages and granulocytes under inflammatory conditions. Although increased levels of chitotriosidase and YKL-40 are linked with several inflammatory diseases, the physiological utility of these two enzymes is still not fully characterized. This study aims to analyse the serum YKL-40 and chitotriosidase levels of acute pancreatitis patients to assess whether their activity correlates with acute pancreatitis and its severity. Materials and methods: Chitotriosidase and YKL-40 levels, along with routine laboratory parameters, were determined from the serum samples of 41 acute pancreatitis patients, at both onset and remission (male/female: 22/19), and 39 healthy subjects (male/female: 19/20). The Modified Glasgow Prognostic Score was used to predict the severity of the disease, and a correlation analysis was performed between study variables. Results: A statistically significant increase in both chitotriosidase and YKL-40 levels was observed in acute pancreatitis patients compared to healthy controls (P < 0.001). Higher levels of YKL-40, chitotriosidase and C-reactive protein were found in patients with acute pancreatitis at onset than in remission. The correlation analysis showed a statistically significant association between YKL-40 and chitotriosidase (p = 0.039, r = 0.323). The cut-off point for YKL-40, for detecting acute pancreatitis, was 60.3 with a sensitivity and specificity of 84.9% and 84.6% (AUC: 0.890). The optimum cut-off points for chitotriosidase, for detecting acute pancreatitis, was 33.5 with a sensitivity and specificity of 79.5% and 78.4% (AUC: 0.899). Conclusion: Elevated YKL-40 and chitotriosidase levels in acute pancreatitis patients demonstrate the importance of possible macrophage involvement in the pancreatic microenvironment during acute pancreatitis progression.
引用
收藏
页码:3038 / 3046
页数:9
相关论文
共 50 条
  • [41] Serum YKL-40 Level Is Correlated with Disease Severity in Patients with Obstructive Sleep Apnea Syndrome: A Meta-Analysis
    Liu, S.
    Bai, M.
    Tong, X.
    Yang, X.
    Wang, D.
    Fan, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [42] Association of serum YKL-40 levels with the presence and severity of coronary artery disease in patients with obstructive sleep apnea syndrome
    Sui, Xizhong
    Gao, Changqing
    CLINICAL AND INVESTIGATIVE MEDICINE, 2013, 36 (06): : E306 - E311
  • [43] Serum YKL-40 as a marker of liver fibrosis and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
    Mano, Yohei
    Kumagai, Erina
    Shoji, Hirotaka
    Yoshio, Sachiyo
    Sugiyama, Masaya
    Korenaga, Masaaki
    Arai, Taeang
    Itokawa, Norio
    Atsukawa, Masanori
    Hyogo, Hideyuki
    Chayama, Kazuaki
    Ohashi, Tomohiko
    Ito, Kiyoaki
    Yoneda, Masashi
    Kawaguchi, Takumi
    Torimura, Takuji
    Nozaki, Yuichi
    Mizokami, Masashi
    Kanto, Tatsuya
    HEPATOLOGY, 2016, 64 : 799A - 799A
  • [44] Prognostic value of serum interleukin-6 and YKL-40 and systemic inflammatory response in patients with unresectable pancreatic cancer.
    Chen, Inna
    Dehlendorff, Christian
    Jensen, Benny Vittrup
    Pfeiffer, Per
    Bjerregaard, Jon K.
    Johansen, Astrid Zedlitz
    Nielsen, Svend Erik
    Andersen, Fahimeh
    Hollander, Niels Henrik
    Yilmaz, Mette K. N.
    Rasmussen, Louise Skau
    Johansen, Julia S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [45] Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS)
    Hessam, Schapoor
    Sand, Michael
    Gambichler, Thilo
    Bechara, Falk G.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (06) : 998 - 1005
  • [46] Serum soluble suppression of tumorigenicity 2 as a novel inflammatory marker predicts the severity of acute pancreatitis
    Yan Zhang
    Bo Cheng
    Zhong-Wei Wu
    Zong-Chao Cui
    Yao-Dong Song
    San-Yang Chen
    Yan-Na Liu
    Chang-Ju Zhu
    World Journal of Gastroenterology, 2021, (38) : 6489 - 6500
  • [47] Serum soluble suppression of tumorigenicity 2 as a novel inflammatory marker predicts the severity of acute pancreatitis
    Zhang, Yan
    Cheng, Bo
    Wu, Zhong-Wei
    Cui, Zong-Chao
    Song, Yao-Dong
    Chen, San-Yang
    Liu, Yan-Na
    Zhu, Chang-Ju
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (38) : 6489 - 6500
  • [48] Inflammatory markers in acute myocardial infarction and the correlation with the severity of coronary heart disease
    Oprescu, Nicoleta
    Micheu, Miruna Mihaela
    Scafa-Udriste, Alexandru
    Popa-Fotea, Nicoleta-Monica
    Dorobantu, Maria
    ANNALS OF MEDICINE, 2021, 53 (01) : 1040 - 1046
  • [49] The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies
    Wennstrom, Malin
    Surova, Yulia
    Hall, Sara
    Nilsson, Christer
    Minthon, Lennart
    Hansson, Oskar
    Nielsen, Henrietta M.
    PLOS ONE, 2015, 10 (08):
  • [50] Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody
    Lili Jiang
    Youlian Wang
    Qinglin Peng
    Xiaoming Shu
    Guochun Wang
    Xiaomu Wu
    Clinical Rheumatology, 2019, 38 : 1655 - 1663